test

Ryan Cappelli

@Prosight Management, Lp

Latest period2024 - Q3ReportedManaged Assets$406.357MTotal holdings45
Assets growth rate21.46%Assets growth rate (2-Q avg)7.27%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Prosight Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Prosight Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 406.357M in assets, with a quarterly growth rate of 21.46% and a 2-quarter average growth rate of 7.27%. The portfolio is managed by Ryan Cappelli, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 0.47%
2.63%
$10.666M
554,103 shares@ $19.26 avg price
IMVTImmunovant Inc
Recent Activity
Increased 13.85%
2.6%
$10.549M
370,000 shares@ $28.51 avg price
PRTAProthena Corp Plc
Recent Activity
Increased 68.5%
2%
$8.088M
483,467 shares@ $16.74 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Increased 129.63%
1.76%
$7.144M
62,000 shares@ $115.22 avg price
TECXTectonic Therapeutic Inc
Recent Activity
Increased 104%
1.03%
$4.17M
137,614 shares@ $30.3 avg price
MURAMural Oncology Pub Ltd Co
Recent Activity
Increased 20.02%
0.44%
$1.786M
570,620 shares@ $3.14 avg price
ALRNAileron Therapeutics Inc
Recent Activity
Increased 40.44%
0.33%
$1.317M
372,157 shares@ $3.55 avg price